Wikisage, the free encyclopedia of the second generation, is digital heritage
Brivaracetam: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m (and Neurol 2016 Nov;9(6):474-482. Epub 2016 Sep 1.) |
||
| Line 2: | Line 2: | ||
4n propyl analog of [[levetiracetam]], this and levetiracetam may have potential in the management of progressive myoclonic [[epilepsy|epilepsies]] | 4n propyl analog of [[levetiracetam]], this and levetiracetam may have potential in the management of progressive myoclonic [[epilepsy|epilepsies]] | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/pdf/ndt-11-2967.pdf Profile of brivaracetam and its potential in the treatment of epilepsy]</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622453/pdf/dddt-9-5719.pdf Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset ]</ref> | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/pdf/ndt-11-2967.pdf Profile of brivaracetam and its potential in the treatment of epilepsy]</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622453/pdf/dddt-9-5719.pdf Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset ]</ref>Like levetiracetam (LEV), it is a ligand of the synaptic vesicle protein SV2A<ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066531/pdf/10.1177_1756285616665564.pdf Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base]</ref> | ||
==Links== | ==Links== | ||
Revision as of 18:33, 10 November 2016
-
![(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide](/w/images/thumb/6/64/Brivaracetam3d.png/120px-Brivaracetam3d.png)
(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide
![(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide](/wiki/File:Brivaracetam3d.png)
4n propyl analog of levetiracetam, this and levetiracetam may have potential in the management of progressive myoclonic epilepsies [1][2]Like levetiracetam (LEV), it is a ligand of the synaptic vesicle protein SV2A[3]
Links
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm486827.htm
ATC
- ↑ Profile of brivaracetam and its potential in the treatment of epilepsy
- ↑ Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset
- ↑ Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base
- ↑ http://www.whocc.no/atc_ddd_index/?code=N03AX23